| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |